300858SZSE
First Capital Securities Co., Ltd. on the Sponsorship Summary Report for Beijing Kete Hengtong Biotechnology Co., Ltd.'s 2022 Private Placement and Listing on the Growth Enterprise Market
Full Translation
Notes & Comments
Sign in to leave a comment or private note.
Loading…